This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_STOMACH_ADENO_EXALLC for full statistics.
Adenocarcinoma and papillary adenocarcinoma of stomach
C3_STOMACH_ADENO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1061 |
4. Check minimum number of eventsNone |
1061 |
5. Include endpointsNone |
1061 |
6. Filter based on genotype QC (FinnGen only) |
1061 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and papillary adenocarcinoma of stomach
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1061 | 305 | 756 |
| Unadjusted period prevalence (%) | 0.27 | 0.10 | 0.33 |
| Median age at first event (years) | 67.71 | 65.08 | 68.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 998
- Matched controls
- 9978
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
300.5
323.0
376
20
130
Kela drug reimbursment
Malignant tumour
24.7
323.0
570
510
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
306.5
278
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
279.7
255
*
107
Kela drug reimbursment
Pernicious anaemia
43.5
248.4
310
102
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
388.2
244.7
237
8
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
+∞
225.8
208
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.8
218.8
562
1155
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
8.9
216.4
678
1916
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
89.1
207.8
228
33
B03BA03
ATC
hydroxocobalamin; parenteral
14.9
205.1
374
385
L01BC06
ATC
capecitabine; oral
29.9
200.8
276
126
C16.00
ICD-10 Finland
Cardia
382.5
190.4
186
6
A04AA02
ATC
granisetron; systemic, transdermal
16.1
157.7
270
224
H02AB02
ATC
dexamethasone; systemic
10.4
157.0
344
480
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
542.7
145.3
141
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
398.3
141.6
139
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
65.0
137.8
159
29
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
743.4
135.0
130
*
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
345.9
122.1
121
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.8
119.6
204
160
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
608.0
112.2
109
*
B81
ICPC
Anaemia vit B12/folate deficiency
13.1
109.7
203
190
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
64.7
103.9
120
21
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.4
95.1
198
231
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
178.7
94.0
97
6
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
+∞
90.0
85
*
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
478.7
89.7
88
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
39.6
89.3
113
32
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
442.8
83.3
82
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
13.1
83.0
152
135
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
154.6
81.4
85
6
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
214.1
77.4
79
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
211.1
76.3
78
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
57.3
75.6
89
17
Z51.5
ICD-10 Finland
Palliative care
6.8
74.8
205
363
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
108.5
74.1
80
8
R4190
NOMESCO Finland
Nutritional therapy
13.8
72.6
129
106
JN4BD
NOMESCO Finland
Extensive body CT
5.3
70.8
247
587
N02AA05
ATC
oxycodone; systemic
4.1
68.5
322
1032
A04AA01
ATC
ondansetron; systemic, rectal
7.7
66.5
165
250
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
239.0
66.0
67
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
18.7
60.3
94
55
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.1
58.2
114
114
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
+∞
56.8
54
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.7
56.1
112
116
JAH01
NOMESCO Finland
Laparoscopy
9.9
56.0
117
132
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
193.7
53.5
55
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
53.3
150
268
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
+∞
52.6
50
*
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
+∞
51.5
49
*
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
116.2
51.3
55
5
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
257.2
48.5
49
*
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
+∞
47.3
45
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.4
47.1
152
320
JAH00
NOMESCO Finland
Laparotomy
9.3
45.2
97
114
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.7
44.9
138
273
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.3
43.8
110
166
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
+∞
43.0
41
*
A04AA55
ATC
palonosetron, combinations; systemic
13.9
42.5
74
57
6322
FHL
Gastrectomy (including Roux-Y)
413.3
40.4
40
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.4
40.3
100
148
D74
ICPC
Malignant neoplasm stomach
145.9
40.0
42
*
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
87.6
38.1
42
5
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
202.6
38.1
39
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
30.9
37.7
50
17
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
101.3
36.0
39
*
L01BC53
ATC
tegafur, combinations; systemic
186.4
35.0
36
*
C16
ICD-10 Finland
Malignant neoplasm of stomach
186.4
35.0
36
*
WX600
NOMESCO Finland
Single shot through catheter
17.6
34.9
55
33
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
21.4
34.7
51
25
A04AD12
ATC
aprepitant; systemic
14.7
33.7
57
41
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
175.7
32.9
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.3
32.5
80
117
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
63.9
32.2
37
6
B01AB05
ATC
enoxaparin; parenteral
2.4
31.9
364
1933
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
18.3
31.7
49
28
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
15.6
31.6
52
35
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
20.5
31.6
47
24
L03AA02
ATC
filgrastim; parenteral
8.2
31.5
72
94
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
322.4
31.0
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.4
29.6
93
187
UJD02
NOMESCO Finland
Gastroscopy
4.2
28.9
116
301
UJC12
NOMESCO Finland
Flexible oesophagoscopy
19.1
28.9
44
24
R11
ICD-10 Finland
Nausea and vomiting
3.8
28.9
130
374
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
300.2
28.9
29
*
A02BC02
ATC
pantoprazole; systemic
2.1
28.5
658
4728
8140/3-C16.2
ICD-O-3
Adenocarcinoma, NOS, of body of stomach
+∞
28.3
27
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
27.8
329
1754
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.5
27.5
54
54
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
15.3
26.7
44
30
JN4AD
NOMESCO Finland
Body CT examination
3.6
26.6
127
384
JKA20
NOMESCO Finland
Cholecystectomy
5.4
26.2
81
160
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
25.0
155
568
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
39.9
25.0
31
8
WZC30
NOMESCO Finland
Teaching
2.9
24.9
165
632
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
133.3
24.7
26
*
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
19.2
24.5
37
20
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.8
23.2
47
50
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.9
22.6
52
69
A98
ICPC
Health maint/preventive medicine
0.5
22.5
535
6928
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
+∞
21.9
21
*
JFF00
NOMESCO Finland
Catheter enterostomy
78.5
20.7
23
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.4
20.7
78
190
WX402
NOMESCO Finland
General anaesthesia
2.6
20.0
158
669
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
58.7
20.0
23
*
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
+∞
19.9
19
*
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
+∞
19.9
19
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
16.8
19.7
31
19
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
107.1
19.6
21
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
19.4
239
1263
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
19.4
74
183
R18
ICD-10 Finland
Ascites
7.4
19.2
46
65
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
20.5
19.1
28
14
ZX120
NOMESCO Finland
Intravenous
2.9
18.8
124
470
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
18.6
134
537
K92.0
ICD-10 Finland
Haematemesis
4.9
18.6
62
134
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
5.9
18.5
52
92
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
7.6
18.4
43
59
376
Kela drug reimbursment
Cyanocobalamin
+∞
17.8
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
17.4
260
1480
A06AH03
ATC
naloxegol; oral
11.4
17.3
32
29
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.5
17.1
37
45
K22.2
ICD-10 Finland
Oesophageal obstruction
9.3
17.0
35
39
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
+∞
16.7
16
*
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
+∞
16.7
16
*
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
16.7
16
*
B01AB10
ATC
tinzaparin; parenteral
3.3
16.6
88
288
L03AA13
ATC
pegfilgrastim; parenteral
4.7
16.3
55
121
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
34.0
15.8
20
6
T91
ICPC
Vitamin/nutritional deficiency
12.0
15.6
28
24
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
162.4
15.5
16
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.7
15.5
39
60
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
14.6
105
419
WW500
NOMESCO Finland
Blood transfusion
3.5
14.6
69
207
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
14.5
28
28
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
8.4
14.3
31
38
R13
ICD-10 Finland
Dysphagia
2.9
14.3
92
343
JDC11
NOMESCO Finland
Laparoscopic partial gastrectomy and gastrojejunostomy
76.2
13.6
15
*
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
141.8
13.5
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.1
13.4
36
61
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.4
13.4
48
113
C10AA05
ATC
atorvastatin; oral
0.5
13.4
180
2879
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
14.0
13.3
22
16
K92.1
ICD-10 Finland
Melaena
2.7
13.1
92
362
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
7.8
12.9
29
38
JDE00
NOMESCO Finland
Gastrojejunostomy
19.3
12.9
19
10
A09AA02
ATC
multienzymes (lipase, protease etc.)
5.3
12.7
38
74
N40
ICD-10 Finland
Hyperplasia of prostate
0.5
12.6
142
2396
ZX121
NOMESCO Finland
Central venous catheter
32.5
12.6
16
5
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
+∞
12.5
12
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
12.4
372
4918
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
12.2
69
235
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.3
12.1
44
105
D77
ICPC
Malignant digestive neopl other/NOS
27.0
12.1
16
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
12.0
70
246
8140/3-C16.4
ICD-O-3
Adenocarcinoma, NOS, of pylorus
+∞
11.5
11
*
C16.1
ICD-10 Finland
Malignant neoplasm: Fundus of stomach
121.3
11.4
12
*
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
121.3
11.4
12
*
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
121.3
11.4
12
*
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
7.7
11.2
25
33
K91.1
ICD-10 Finland
Postgastric surgery syndromes
25.3
11.2
15
6
RD210
NOMESCO Finland
NA
6.2
11.1
29
48
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.3
11.1
20
18
TPX15
NOMESCO Finland
Removal of vascular injection port
14.1
11.0
18
13
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
43.8
10.9
13
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
10.8
159
884
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.9
10.8
29
50
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
+∞
10.4
10
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.3
10.4
38
92
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
23.6
10.3
14
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
10.2
185
1109
SPAT1053
SPAT
Memory test
0.4
10.1
53
1155
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.9
10.1
32
67
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.7
9.9
22
29
M01AH05
ATC
etoricoxib; oral
0.6
9.9
238
3358
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
26.3
9.8
13
5
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
9.7
143
795
JFC00
NOMESCO Finland
Entero-enterostomy
55.5
9.7
11
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
9.6
43
998
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
12.5
9.4
16
13
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.3
402
3044
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.8
9.2
25
44
B01AB04
ATC
dalteparin; parenteral
2.7
9.2
63
246
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
37.0
9.0
11
*
L03AA14
ATC
lipegfilgrastim; parenteral
5.0
8.8
27
55
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
14.2
8.7
14
10
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.8
8.7
35
94
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.9
8.6
34
90
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
11.7
8.6
15
13
A02BC05
ATC
esomeprazole; systemic
1.5
8.6
341
2521
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
27.8
8.5
11
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
27.8
8.5
11
*
V03AF03
ATC
calcium folinate; systemic
20.2
8.5
12
6
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
5.7
8.5
23
41
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
90.8
8.4
9
*
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
90.8
8.4
9
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
90.8
8.4
9
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.5
8.3
98
1659
8145/3-C16.4
ICD-O-3
Carcinoma, diffuse type of pylorus
+∞
8.3
8
*
C16.14
ICD-10 Finland
Malignant tumor of the fundus ventriculi intestinal carcinoma
+∞
8.3
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
8.3
45
153
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.1
8.3
19
27
A02BC03
ATC
lansoprazole; oral
1.6
8.2
282
2005
A02BX02
ATC
sucralfate; oral
2.5
8.0
62
260
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.0
278
1983
C09CA01
ATC
losartan; oral
0.6
7.8
96
1609
WX704
NOMESCO Finland
Intubation
2.4
7.7
65
284
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
7.5
7.7
17
23
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.8
7.7
24
51
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.6
125
721
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
18.5
7.6
11
6
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
7.5
84
1444
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
7.4
39
850
C08CA01
ATC
amlodipine; oral
0.6
7.4
197
2756
Z31.5
ICD-10 Finland
Genetic counselling
3.4
7.4
33
98
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
7.3
204
2831
TJF00
NOMESCO Finland
Insertion of jejunal tube
+∞
7.3
7
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
N06DA02
ATC
donepezil; oral
0.3
7.3
12
436
RD160
NOMESCO Finland
NA
15.9
7.2
11
7
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.1
129
769
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.7
7.1
46
176
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.9
132
800
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.5
6.9
52
1004
ZXC86
NOMESCO Finland
Use of endoscopic device
8.3
6.8
14
17
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.8
113
1759
L01BC04
ATC
carmofur; oral
16.8
6.7
10
6
P20
ICPC
Memory disturbance
0.5
6.7
44
889
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.6
6.7
28
79
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
22.7
6.7
9
*
A79
ICPC
Malignancy NOS
4.5
6.7
22
50
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.3
6.6
11
9
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
6.5
256
3342
M25.5
ICD-10 Finland
Pain in joint
0.6
6.5
76
1289
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
6.4
50
958
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
70.3
6.4
7
*
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
6.3
6
*
1510E
ICD-9 Finland
Malignant neoplasm of stomach, Cardia[MAHASYÖPÄ,KARDIA,MUU TARK MÄÄR CA]
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
26.8
6.2
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
26.8
6.2
8
*
N06DX01
ATC
memantine; oral
0.3
6.2
18
498
TJK00
NOMESCO Finland
Intraoperative cholangiography
7.7
6.1
13
17
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
6.1
167
2338
A55
ICPC
General and Unspecified, Local injection/infiltration
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
433
903
7.41
216.47
6.5
4.1
ug/l
27.9
28.5
0.02
406
768
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
247
327
9.54
183.34
6.0
3.3
u/ml
663.9
12581.3
0.77
231
272
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
173
177
11.48
154.69
4.7
3.4
u/ml
153.1
2118.4
0.77
164
166
(40768797) Stomach Pathology biopsy report
346
983
4.74
114.09
1.9
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
72
28
27.51
104.66
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
272
764
4.44
88.91
3.3
2.2
g/l
0.2
0.2
0.02
264
704
(3012095) Magnesium [Moles/volume] in Serum or Plasma
293
1290
2.76
43.64
3.7
3.1
mmol/l
0.8
0.8
0.17
279
1191
(4035726)
186
656
3.23
41.16
1.7
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
491
6975
0.45
35.44
3.9
5.2
mmol/l
2.4
2.6
2.81
434
6253
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
465
6643
0.47
32.04
6.3
6.4
mmol/mol
41.3
41.1
0.21
417
6024
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
481
6781
0.47
31.75
3.5
4.6
mmol/l
4.3
4.4
0.92
428
6135
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
475
6714
0.47
31.34
3.4
4.6
mmol/l
1.5
1.4
3.00
415
6014
(3024561) Albumin [Mass/volume] in Serum or Plasma
530
3537
2.00
26.45
10.5
4.8
g/l
32.2
34.5
16.18
514
3268
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
449
6289
0.50
25.65
4.2
4.4
mu/l
2.0
2.2
0.61
401
5567
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
472
6503
0.51
25.57
3.3
4.1
mmol/l
1.2
1.3
2.35
414
5783
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
398
2436
2.01
25.08
3.3
2.5
u/l
67.3
57.0
1.68
372
2242
(3003458) Phosphate [Moles/volume] in Serum or Plasma
225
1122
2.28
24.08
4.4
5.5
mmol/l
1.0
1.0
1.05
217
1029
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
522
6908
0.52
23.88
4.1
4.9
mmol/l
6.1
6.1
0.39
468
6131
(3000963) Hemoglobin [Mass/volume] in Blood
619
7729
0.52
22.58
45.5
25.4
g/l
118.6
133.5
95.30
601
7536
(3026361) Erythrocytes [#/volume] in Blood
619
7728
0.52
22.55
45.3
25.2
e12/l
4.1
4.4
48.97
591
7423
(3007461) Platelets [#/volume] in Blood
619
7727
0.52
22.52
45.3
25.3
e9/l
264.8
236.5
13.77
595
7454
(3035941) MCH [Entitic mass]
619
7727
0.52
22.52
45.1
25.1
pg
29.7
30.5
14.36
603
7534
(3024731) MCV [Entitic volume]
619
7726
0.52
22.49
45.1
25.2
fl
90.8
91.8
4.37
603
7535
(3010813) Leukocytes [#/volume] in Blood
620
7731
0.52
22.37
45.2
25.3
e9/l
7.5
7.0
1.18
590
7427
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
207
3.55
20.16
1.7
1.4
ug/g
251.6
271.7
0.43
61
116
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
552
4070
1.74
17.27
15.2
6.3
umol/l
11.7
12.5
0.67
539
3846
(3023103) Potassium [Moles/volume] in Serum or Plasma
616
7522
0.57
17.26
36.3
20.7
mmol/l
4.0
4.0
6.00
594
7269
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
608
7440
0.57
16.98
19.4
11.0
u/l
30.4
25.8
0.72
588
7098
(3019550) Sodium [Moles/volume] in Serum or Plasma
616
7505
0.57
16.81
36.2
20.6
mmol/l
138.8
139.6
10.50
596
7259
(40761511) CBC panel - Blood by Automated count
590
7250
0.58
16.28
29.6
16.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
364
5047
0.58
15.72
3.5
3.6
pmol/l
14.6
15.0
2.36
326
4444
(3044640) Blood type and Crossmatch panel - Blood
366
2457
1.75
15.57
3.9
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
259
3890
0.56
14.61
3.8
5.3
ug/l
2.2
4.9
1.70
228
3418
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
167
900
2.02
14.09
4.1
2.9
umol/l
10.2
9.2
0.17
150
798
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
715
2.12
14.01
5.0
2.4
u/l
37.2
33.2
0.56
130
606
(3022948) Iron [Moles/volume] in Serum or Plasma
227
1378
1.82
13.31
2.4
2.5
umol/l
10.8
12.3
2.06
212
1271
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
126
629
2.14
13.01
1.5
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
534
6582
0.62
12.93
32.9
16.5
ml/min/173m2
81.7
73.4
16.91
475
5483
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
198
3101
0.56
12.38
3.5
4.6
%
23.5
21.6
0.95
93
1587
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
227
3416
0.57
12.24
2.3
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
364
2573
1.63
12.09
5.1
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
248
1588
1.73
11.99
7.4
3.1
mmol/l
2.5
2.5
0.41
240
1374
(3032080) INR in Blood by Coagulation assay
475
3589
1.59
11.90
9.4
11.2
inr
1.3
1.3
1.15
139
982
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
320
2204
1.65
11.72
2.6
2.2
mg/l
3.4
3.1
0.79
293
1855
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
327
2273
1.63
11.51
5.3
3.3
u/l
43.2
35.5
0.95
321
2150
(3004789) Transferrin [Mass/volume] in Serum or Plasma
203
1250
1.77
11.18
2.3
2.5
g/l
2.5
2.2
6.12
189
1149
(3020779) Urea [Moles/volume] in Serum or Plasma
140
777
1.92
10.73
4.3
7.0
mmol/l
8.2
11.5
5.62
130
730
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
330
2.37
10.47
2.1
2.4
u/ml
0.4
0.4
0.08
38
191
(3026493) Urate [Moles/volume] in Serum or Plasma
119
2079
0.52
10.43
2.1
2.9
umol/l
3349.3
7521.4
0.70
104
1752
(3013707) Erythrocyte sedimentation rate by Westergren method
419
5324
0.65
10.41
3.6
4.1
mm/h
14.7
14.4
0.14
378
4827
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
453
3460
1.54
10.39
5.8
4.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
2183
0.53
10.36
2.4
3.3
ug/l
0.8
0.8
0.63
95
1523
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
274
1869
1.63
10.22
3.5
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
91
441
2.16
10.11
11.4
9.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
149
2399
0.56
9.81
2.8
3.2
mg/l
509.1
289.1
0.20
95
1589
(3015377) Calcium [Moles/volume] in Serum or Plasma
362
2663
1.55
9.68
6.6
3.3
mmol/l
2.3
2.3
4.35
347
2287
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
188
1188
1.71
9.33
2.3
2.5
%
17.9
22.4
3.52
157
1020
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
611
7119
0.67
9.28
31.4
17.5
mg/l
38.4
28.2
9.73
561
5834
(3020682) Albumin/Creatinine [Ratio] in Urine
165
2540
0.59
9.07
3.3
4.0
mg/mmol
13.7
9.4
0.40
107
1646
(3013650) Neutrophils [#/volume] in Blood by Automated count
515
4136
1.48
8.78
15.6
8.7
e9/l
4.1
4.3
0.44
469
3614
(3009542) Hematocrit [Volume Fraction] of Blood
512
6134
0.68
8.60
34.2
18.6
%
35.4
38.7
11.97
323
3847
(1761868) Lipid panel - Serum or Plasma
127
2054
0.57
8.30
2.7
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
107
1815
0.54
8.27
1.7
1.7
mmol/l
1.2
1.3
2.21
87
1489
(3009508) Creatinine [Moles/volume] in Urine
162
2440
0.60
7.99
2.7
3.1
mmol/l
8.2
7.6
0.99
125
1987
(3002173) Hemoglobin [Mass/volume] in Arterial blood
135
823
1.73
7.57
10.8
7.4
g/l
113.4
120.3
3.84
130
791
(4281824)
23
65
3.59
7.17
1.1
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
10
5
20.17
7.14
1.3
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
49
214
2.35
7.02
3.4
3.1
u/ml
49.3
47.2
0.04
49
204
(3003338) MCHC [Mass/volume]
476
5662
0.71
6.83
41.3
22.8
g/l
326.9
331.9
23.45
467
5584
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
45
955
0.45
6.76
1.3
1.3
u/ml
81.7
15.3
0.43
21
333
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
206
2830
0.66
6.47
2.8
3.2
ng/l
2133.6
2059.4
0.06
189
2454
(3002256) Pathology report gross observation
146
973
1.58
5.77
1.6
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
236
1747
1.45
5.66
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
113
719
1.64
5.40
11.2
7.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
138
922
1.57
5.39
10.6
6.9
%
96.4
95.1
2.47
132
883
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
944
0.51
5.37
2.9
4.7
%
34.8
32.0
1.03
36
613
(3002385) Erythrocyte distribution width [Ratio]
488
5648
0.75
5.11
39.3
21.0
%
15.3
13.9
38.84
476
5503
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
183
2473
0.69
5.07
1.9
2.2
u/l
646.8
254.7
0.52
165
2304
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
87
526
1.71
5.05
1.7
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
14
36
3.93
4.99
1.7
2.2
e6/l
509.5
774.1
—
8
30
(3044889) 12 lead EKG panel
446
5216
0.75
4.96
4.7
4.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
148
1026
1.51
4.90
10.0
6.8
mmol/l
1.3
1.2
0.06
121
771
(3037467) Urinalysis macro (dipstick) panel - Urine
439
5138
0.75
4.87
4.3
4.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
49
254
1.97
4.66
1.5
1.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
29
4.17
4.63
1.8
2.0
e6/l
726.0
57656.4
—
5
19
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
1012
0.56
4.62
1.3
1.3
iu/ml
15.9
38.8
4.03
16
326
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
146
1023
1.50
4.59
10.3
6.7
kpa
5.1
5.1
0.18
139
969
(3027801) Oxygen [Partial pressure] in Arterial blood
146
1024
1.49
4.57
10.3
6.7
kpa
12.7
11.6
1.85
139
972
(3007164) IgA [Mass/volume] in Serum or Plasma
73
1173
0.59
4.47
1.2
1.4
g/l
2.6
2.8
0.36
44
679
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
26
4.26
4.36
1.0
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
44
807
0.53
4.33
1.3
1.3
titre
400.0
431.4
0.08
11
187
(40758558) Short blood count panel - Blood
233
1802
1.38
4.26
10.9
6.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
33
153
2.19
4.21
1.7
3.9
%
1.7
1.6
0.07
26
123
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
73
2.77
4.20
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
49
266
1.88
4.10
5.6
6.1
mmol/l
1.5
1.4
0.14
42
230
(3001122) Ferritin [Mass/volume] in Serum or Plasma
359
2979
1.31
4.06
3.4
2.8
ug/l
81.8
161.8
14.74
337
2680
(3006653) Thiamine [Moles/volume] in Blood
13
37
3.54
4.06
1.2
1.1
nmol/l
115.2
134.7
1.39
13
37
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
465
3997
1.29
4.02
9.2
6.7
mmol/l
1.2
1.2
4.85
382
3319
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
139
2.19
3.86
2.4
2.9
e9/l
4.4
4.6
0.10
30
139
(3042936) Bacteria identified in Isolate by Culture
163
1206
1.42
3.85
1.9
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
1548
0.67
3.83
1.5
1.7
mg/l
2.4
1.4
2.37
92
1213
(40768804) Tissue Pathology biopsy report
332
2750
1.30
3.75
2.9
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
292
2386
1.31
3.63
5.1
4.0
ph
7.4
7.4
0.44
72
468
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
195
0.25
3.56
1.6
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
98
672
1.50
3.44
4.9
3.8
mmol/l
1.2
1.2
0.55
88
587
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
146
2.09
3.44
3.3
3.5
%
59.2
60.1
0.12
30
146
(3031040) Bacteria [#/volume] in Urine by Automated count
449
5088
0.80
3.29
4.5
4.8
e6/l
8257.9
2309.9
—
9
102
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
618
0.54
3.29
1.5
2.3
nmol/l
14.8
12.4
0.58
29
542
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
163
1.99
3.27
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
221
0.31
3.20
1.3
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
36
194
1.89
3.14
6.6
6.6
mmol/l
106.1
105.3
0.53
31
172
(3039000) Anion gap in Blood
36
194
1.89
3.14
6.6
6.6
mmol/l
10.6
11.4
0.79
31
172
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
419
3645
1.25
3.04
8.2
6.0
mmol/l
1.2
1.2
4.45
400
3264
(3017181) Myelocytes/100 leukocytes in Blood
90
624
1.48
3.02
2.2
4.0
%
1.2
0.9
0.64
42
215
(3018677) aPTT in Platelet poor plasma by Coagulation assay
168
1301
1.35
3.01
2.0
2.0
s
31.3
30.1
0.61
168
1262
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
633
0.57
2.92
1.5
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
30
3.36
2.91
1.8
2.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
13
5.41
2.87
1.1
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
422
0.49
2.81
1.8
2.5
—
10.5
—
0
14
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
68
452
1.54
2.80
15.2
8.9
mmol/l
24.3
24.4
0.14
68
416
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
981
0.66
2.75
12.8
8.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
113
833
1.40
2.75
3.7
3.7
mmol/l
2.5
2.1
0.48
84
644
(3002179) Metamyelocytes/100 leukocytes in Blood
80
553
1.48
2.74
2.2
4.0
%
0.6
0.6
0.00
26
156
(3013512) EKG study
200
2445
0.78
2.67
4.3
4.2
—
—
—
0
0
(1002224) Polysomnography panel
7
202
0.34
2.67
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
83
584
1.46
2.62
2.3
4.1
%
0.0
0.2
2.54
37
198
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
3346
0.81
2.44
3.7
4.2
ng/l
32.1
59.6
1.77
236
2583
(3017704) Immunofixation for Urine
0
63
0.00
2.43
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
27
3.35
2.39
2.2
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
652
0.63
2.30
2.5
2.2
ug/g
228.0
145.2
1.07
35
518
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
157
0.32
2.28
1.2
1.2
u/l
20.2
39.1
—
5
134
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
377
0.52
2.25
1.0
1.4
—
48.9
—
0
20
(3009261) Glucose [Presence] in Urine by Test strip
315
3596
0.82
2.20
3.6
4.0
estimate
0.0
0.0
0.50
66
667
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
54
2.42
2.20
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
80
581
1.41
2.16
7.3
6.4
mmol/l
25.5
24.3
1.85
75
541
(3027945) Reticulocytes/100 erythrocytes in Blood
139
1100
1.30
2.16
1.8
2.5
%
1.6
1.8
0.94
124
984
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
183
0.38
2.16
1.4
1.8
nmol/l
66.0
43.8
—
7
173
(3021601) Nitrite [Presence] in Urine by Test strip
310
3536
0.83
2.13
5.2
5.3
estimate
0.0
0.0
0.00
67
680
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
56
382
1.49
2.10
5.7
4.8
%
1.7
1.6
0.52
51
357
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
96
1254
0.74
2.08
1.1
1.2
u/ml
1.1
1.5
0.49
31
302
(21494815) CD4 cells/100 lymphocytes in Specimen
0
55
0.00
2.07
0.0
1.8
—
35.7
—
0
8
(3035350) Ketones [Presence] in Urine by Test strip
313
3551
0.83
2.01
3.7
3.9
estimate
0.0
0.0
0.00
67
686
(3007930) Methemoglobin/Hemoglobin.total in Blood
55
379
1.48
1.98
5.8
4.9
%
0.9
0.9
0.15
50
354
(40760892) CBC W Ordered Manual Differential panel - Blood
173
1433
1.25
1.88
3.4
4.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
81
606
1.36
1.87
5.2
4.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
214
1815
1.22
1.87
1.9
1.8
pmol/l
458.0
10731797.3
1.06
176
1463
(3010421) pH of Blood
39
253
1.56
1.86
2.2
4.3
ph
7.4
7.4
0.09
32
210
(40768800) Prostate Pathology biopsy report
12
250
0.47
1.86
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
549
1.37
1.80
2.4
4.1
%
0.0
0.1
1.26
30
166
(3023520) Reticulocytes [#/volume] in Blood
104
813
1.31
1.80
2.0
2.7
e9/l
58.3
67.8
2.00
81
642
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
167
0.42
1.79
1.0
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
334
0.56
1.75
1.4
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
137
1667
0.80
1.74
3.1
3.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
96
1.89
1.71
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
96
1.89
1.71
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
96
1.89
1.71
1.2
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
47
0.00
1.70
0.0
18.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2068
1.20
1.70
1.9
1.6
nmol/l
21.6
19.8
1.20
220
1745
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
97
1.87
1.66
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
97
1.87
1.66
1.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
127
1.75
1.65
3.3
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
148
0.40
1.64
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
718
0.71
1.63
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
98
1.85
1.62
1.3
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
33
214
1.56
1.61
2.4
4.6
mmol/l
3.1
2.4
0.96
24
146
(3013826) Glucose [Moles/volume] in Serum or Plasma
503
4654
1.15
1.54
7.8
4.9
mmol/l
6.6
6.9
2.49
485
4380
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
232
0.51
1.53
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
524
0.68
1.52
2.5
3.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
131
1.69
1.50
1.3
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
211
1.53
1.47
1.9
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
328
0.60
1.46
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
152
0.46
1.44
1.9
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
295
1.44
1.44
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
433
0.66
1.41
2.2
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
300
0.59
1.40
2.0
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
675
0.73
1.40
1.6
1.8
%
1.6
1.6
0.04
42
561
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
559
0.70
1.38
2.2
3.7
mmol/l
3.6
1.9
1.05
26
411
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
209
0.52
1.35
1.4
1.4
g/l
1.1
1.1
0.19
11
202
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
259
0.57
1.34
1.4
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
147
0.47
1.32
2.3
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
319
0.62
1.32
1.2
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
173
0.52
1.30
2.7
2.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
87
698
1.27
1.29
3.6
2.9
kpa
4.5
4.4
0.04
82
667
(36660697) Celiac disease serology panel - Serum
31
445
0.69
1.26
1.1
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
200
0.55
1.20
1.4
1.4
g/l
0.2
0.2
0.32
11
193
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
129
0.46
1.16
3.3
3.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
13
72
1.82
1.15
1.6
3.3
mg/l
22.6
33.6
—
8
63
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
494
0.72
1.15
1.5
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
20
2.51
1.15
2.0
1.4
g/l
28.8
24.6
—
5
15
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
153
0.52
1.14
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
48
626
0.76
1.11
1.3
2.5
—
—
—
0
0
(3000492) Spirometry study
75
604
1.26
1.10
1.4
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
138
0.50
1.10
1.0
1.2
mmol/l
3.4
3.9
—
7
128
(3037756) Immunofixation for Serum or Plasma
12
206
0.58
1.09
1.2
1.6
—
—
—
0
0
(4010399)
38
511
0.73
1.08
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
166
0.54
1.08
1.9
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
688
0.77
1.06
2.8
3.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
54
1.86
0.96
2.7
2.9
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
31
0.00
0.96
0.0
1.0
—
1.1
—
0
18
(3036670) Protein [Mass/volume] in Synovial fluid
0
31
0.00
0.96
0.0
1.1
—
37.0
—
0
17
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
31
0.00
0.96
0.0
4.7
—
65.6
—
0
25
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
32
0.00
0.95
0.0
2.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
185
0.59
0.95
1.2
1.9
mg/l
28.4
12.5
0.42
11
167
(3015183) Erythrocyte sedimentation rate
6
27
2.23
0.93
1.0
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
12
70
1.72
0.92
1.0
1.1
nmol/l
360.6
350.7
0.08
12
58
(3019832) Treponema pallidum Ab [Presence] in Serum
14
220
0.63
0.92
2.1
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
113
1307
0.85
0.90
21.9
30.2
inr
1.3
1.4
0.83
20
183
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
289
0.69
0.89
1.3
1.3
—
—
—
0
0
(4094501)
11
181
0.60
0.88
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
17
111
1.54
0.88
5.3
5.7
mg/l
11.7
12.3
0.24
17
100
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
95
1.59
0.87
1.3
3.7
%
69.0
54.0
—
7
68
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
30
2.01
0.87
1.7
1.5
nmol/l
0.7
1.1
—
6
22
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
204
0.63
0.86
3.2
2.9
mg/l
2.1
1.8
0.31
13
182
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
253
2757
0.89
0.86
4.0
4.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
893
1.18
0.86
6.1
3.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
45
1.78
0.84
1.4
2.5
—
—
—
0
0
(3020891) Body temperature
45
354
1.28
0.84
4.5
4.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
46
1.74
0.82
1.3
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
113
1.51
0.82
1.4
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
619
0.80
0.82
1.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
306
0.71
0.81
1.8
3.0
g/l
0.3
0.2
—
10
124
(3021589) Normoblasts [#/volume] in Blood
292
3147
0.90
0.81
13.1
10.3
e9/l
0.0
0.0
0.42
229
2557
(3026782) Osmolality of Urine
193
1744
1.13
0.81
3.1
3.0
mosm/kgh2o
552.1
563.7
0.31
174
1491
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
350
0.74
0.79
3.3
2.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
26
0.00
0.78
0.0
1.3
—
1.5
—
0
26
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
99
0.50
0.78
1.0
1.5
g/l
0.9
0.9
—
5
72
(3037556) Urate [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
144
1609
0.88
0.74
3.8
4.3
kg/l
1.0
1.0
0.24
20
241
(3044927) Protein electrophoresis panel - Urine
6
109
0.55
0.72
1.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
647
1.19
0.72
2.1
2.0
nmol/l
377.6
376.5
0.02
71
586
(3002582) Erythrocytes [#/volume] in Urine
277
2575
1.10
0.71
3.2
3.5
e6/l
41.7
110.9
1.74
222
2043
(3028433) Virus identified in Specimen by Culture
5
26
1.93
0.70
1.0
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
9
58
1.56
0.70
1.1
1.2
mmol/l
42.0
35.5
—
9
53
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
95
0.52
0.66
1.0
1.1
g/l
1.7
1.6
—
5
85
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
410
4312
0.92
0.66
3.4
3.2
u/l
77.7
57.3
1.38
381
3939
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
591
0.82
0.66
1.3
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
149
1345
1.13
0.65
3.2
3.2
e6/l
2.3
1.6
0.68
93
793
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
360
0.77
0.65
1.2
2.5
g/l
7.4
7.3
0.08
19
267
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
360
0.77
0.65
1.2
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
359
0.77
0.64
1.2
2.5
g/l
3.5
3.8
0.99
18
256
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
29
1.73
0.64
1.0
1.2
%
32.2
25.8
—
5
17
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
130
0.61
0.64
1.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
223
0.71
0.63
1.1
3.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
121
1.41
0.62
1.1
1.4
e6/l
20943.8
83341.6
0.65
11
71
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
8
49
1.64
0.62
1.0
1.6
u/l
—
90.0
—
0
10
(3045424) Erythrocytes [Presence] in Urine
6
104
0.57
0.62
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
50
1.60
0.61
1.8
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
50
1.60
0.61
9.4
3.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
334
0.77
0.61
1.2
2.6
g/l
3.1
3.1
0.05
18
261
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
141
0.64
0.60
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
1707.6
—
0
21
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
409
1.21
0.59
3.7
3.8
mmol/l
23.5
24.0
0.41
44
365
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
52
1.54
0.59
1.3
3.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
64
1.57
0.58
1.4
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
430
0.81
0.58
2.5
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
265
2483
1.09
0.58
3.8
5.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
264
0.75
0.57
1.3
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
199
1841
1.10
0.57
2.0
1.8
nmol/l
1199.1
1180.4
0.10
166
1374
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
22
167
1.32
0.57
1.6
2.6
%
258.1
201.3
1.80
22
159
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
86
0.58
0.56
1.2
1.3
u/l
13.8
13.2
—
5
79
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
373
0.80
0.55
1.1
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
60
1.50
0.54
1.4
1.6
%
8.5
10.8
—
9
60
(3044242) Glucose [Moles/volume] in Arterial blood
9
63
1.43
0.52
2.4
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
177
1910
0.91
0.52
3.7
3.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
45
1.56
0.49
4.4
4.3
—
—
—
0
0
(4034850)
18
234
0.77
0.48
17.7
12.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
247
2327
1.08
0.48
3.1
3.4
e6/l
1.2
0.6
0.73
193
1819
(3023419) Bacteria identified in Sputum by Culture
8
117
0.68
0.46
3.3
2.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
118
0.68
0.46
1.1
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
83
0.60
0.45
1.0
1.4
u/l
11.2
13.9
—
5
76
(3019069) Monocytes/100 leukocytes in Blood
353
3377
1.07
0.45
4.1
5.9
%
9.3
9.0
0.63
337
3129
(3045788) Cell count panel - Pleural fluid
14
103
1.36
0.45
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
432
1.17
0.45
2.3
2.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
593
5770
1.06
0.44
16.5
7.7
u/l
111.8
82.0
9.79
574
5360
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
230
0.78
0.44
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
104
1.35
0.43
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
56
1.43
0.42
1.5
3.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
26
212
1.23
0.42
1.2
3.1
umol/l
30.0
35.7
0.51
21
170
(3000494) Fungus identified in Specimen by Culture
78
867
0.89
0.42
1.5
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
351
3367
1.06
0.41
4.0
5.6
%
2.3
2.9
5.38
334
3109
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
4.1
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
15
0.00
0.41
0.0
5.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
16.0
—
0
15
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.2
—
27.2
—
0
10
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
0.8
—
0
8
(3012441) Differential panel - Pleural fluid
16
123
1.31
0.40
1.2
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
88
1.37
0.40
1.3
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
72
801
0.89
0.40
3.8
4.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
61
1.31
0.39
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
831
0.90
0.39
2.4
2.6
ug/l
4.8
7.0
0.87
59
714
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
358
3443
1.06
0.39
4.2
5.8
%
23.5
25.6
2.40
337
3174
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
722
0.89
0.36
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
328
3409
0.95
0.36
2.4
2.1
pmol/l
84.6
92.5
3.28
234
1797
(3007853) Bacteria identified in Skin by Aerobe culture
101
930
1.10
0.35
1.7
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
122
0.74
0.35
1.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.33
1.2
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.33
1.2
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
296
0.84
0.33
1.1
1.2
iu/ml
115.8
159.4
—
6
105
(3022096) Basophils/100 leukocytes in Blood
340
3283
1.05
0.32
4.0
5.5
%
0.6
0.6
0.44
324
3035
(3024928) Oxygen saturation in Venous blood
22
183
1.21
0.32
3.4
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.1
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
439
0.88
0.28
6.7
3.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
236
2457
0.95
0.28
2.9
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
1511
0.94
0.28
1.7
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
574
0.90
0.28
1.9
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
63
1.27
0.27
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
63
1.27
0.27
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
205
1.17
0.27
2.3
3.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
72
0.69
0.26
1.4
1.2
mmol/l
7.1
7.8
—
5
47
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
396
1.12
0.26
1.1
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
12
149
0.80
0.26
1.3
1.3
nmol/l
0.7
0.9
0.39
12
120
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
75
0.67
0.26
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
127
0.79
0.25
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
191
1989
0.95
0.24
3.3
4.2
estimate
0.0
0.0
0.50
54
650
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
38
1.32
0.23
2.0
2.9
u/l
193.8
213.5
—
5
38
(3042631) Mycobacterium sp identified in Specimen
16
134
1.20
0.23
2.6
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
70
651
1.08
0.22
3.0
4.3
—
—
—
0
0
(44790049)
7
92
0.76
0.22
1.1
1.4
—
—
—
0
0
(44806118)
7
92
0.76
0.22
1.1
1.4
—
—
—
0
0
(44790047)
7
92
0.76
0.22
1.1
1.4
—
—
—
0
0
(44790048)
7
92
0.76
0.22
1.1
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
125
1.20
0.22
1.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
41
1.22
0.22
1.8
1.3
%
1.4
1.2
—
5
32
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
199
0.85
0.21
4.1
3.8
mg/l
62.3
30.0
1.24
11
133
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
6.3
—
0
11
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
338.4
—
0
5
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
108
1024
1.06
0.21
2.2
3.9
u/l
216.0
248.5
3.35
101
968
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.5
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
101
0.79
0.21
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
43
1.16
0.21
1.4
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
2.3
—
0
7
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
375
0.90
0.19
1.8
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
175
0.86
0.19
1.3
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
370
3622
1.03
0.18
3.9
5.5
e9/l
1.6
1.9
1.78
317
3174
(3003181) Sodium [Moles/volume] in Urine
18
156
1.16
0.18
1.3
1.3
mmol/l
60.2
64.0
0.17
13
126
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
132
0.83
0.18
1.2
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
242
1.12
0.18
1.3
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
29
262
1.11
0.17
5.0
4.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
68
1.18
0.16
1.8
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
204
0.88
0.16
1.2
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
339
0.91
0.16
1.6
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
72
1.11
0.16
1.1
1.4
nmol/l
—
—
—
0
0
(4024509)
8
73
1.10
0.15
1.9
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
80
0.75
0.15
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
79
1.14
0.15
8.7
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
192
0.88
0.15
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
83
792
1.05
0.14
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
212
0.89
0.14
1.2
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
98
0.81
0.13
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
98
0.81
0.13
2.4
3.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
592
0.94
0.13
5.8
3.1
ml/min/173m2
59.6
60.0
0.02
23
254
(3003327) Ova and parasites identified in Stool by Light microscopy
15
169
0.89
0.12
1.5
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
148
0.88
0.12
1.1
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
307
3017
1.02
0.12
3.1
3.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
160
1641
0.97
0.11
3.3
4.0
ng/l
725.8
296.5
0.36
132
1408
(3006315) Basophils [#/volume] in Blood
360
3551
1.02
0.10
3.9
5.3
e9/l
0.0
0.0
0.01
303
3048
(3001604) Monocytes [#/volume] in Blood
358
3533
1.02
0.10
3.8
5.3
e9/l
0.7
0.6
1.87
302
3017
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
106
1.13
0.09
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
10
87
1.15
0.09
1.1
1.3
iu/l
50.1
24.3
—
10
69
(3004451) EKG impression Narrative
5
47
1.06
0.09
1.4
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
145
0.90
0.09
1.2
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
124
0.89
0.09
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
459
1.05
0.08
3.2
2.9
e9/l
4.9
4.1
0.46
38
340
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
65
1.08
0.08
1.0
2.1
—
—
—
0
0
(3035880) pH of Pleural fluid
7
68
1.03
0.08
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
104
1066
0.97
0.07
1.7
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
289
2855
1.02
0.07
2.5
2.2
nmol/l
73.8
77.7
1.58
267
2470
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.1
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
76
1.05
0.07
1.1
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
292
2886
1.02
0.07
3.6
4.0
e6/l
61.5
131.6
1.42
229
2174
(3026389) Candida sp identified in Specimen by Organism specific culture
8
78
1.03
0.07
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
112
0.89
0.07
1.1
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
82
0.85
0.07
1.3
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.3
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
84
1.07
0.07
1.3
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
86
1.05
0.07
1.3
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
86
1.05
0.07
1.3
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
99
1.11
0.06
1.1
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
213
0.94
0.06
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
225
2223
1.02
0.06
3.1
3.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
119
1.09
0.06
1.1
1.8
%
84.6
89.6
0.62
13
119
(3018010) Neutrophils/100 leukocytes in Blood
340
3371
1.01
0.05
3.9
5.5
%
59.1
58.8
0.11
322
3130
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
182
0.93
0.05
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
202
0.94
0.05
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
202
0.94
0.05
1.4
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
186
1837
1.02
0.05
2.3
2.7
e6/l
6.2
4.2
2.66
166
1633
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
104
1058
0.98
0.04
1.7
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
605
0.97
0.04
4.3
4.0
ng/l
109.4
98.2
0.30
49
529
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
130
1.08
0.04
2.0
2.2
pg
32.5
32.3
0.03
14
130
(3052851) Hemolysis interference index of Serum or Plasma
26
249
1.05
0.04
5.0
3.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
200
0.95
0.03
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
129
0.93
0.03
1.2
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
84
829
1.01
0.02
2.4
3.1
ng/l
259.5
266.6
0.05
78
754
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
198
0.96
0.02
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
103
1.07
0.02
1.4
4.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
362
1.02
0.01
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
366
3670
1.00
0.01
4.0
5.5
e9/l
0.2
0.2
3.11
313
3214
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
114
0.96
0.00
1.2
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
186
1.02
0.00
1.9
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
194
0.98
0.00
1.9
2.2
g/l
110.5
127.9
1.56
13
143
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
118
1.02
0.00
1.2
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
198
1.01
0.00
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.2
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
117
1.03
0.00
1.6
2.3
u/ml
360.3
41.7
0.41
12
110
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
153
0.98
0.00
1.2
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
195
0.97
0.00
1.8
2.5
%
12.2
15.4
—
7
98
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
95
1.05
0.00
1.9
2.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.3
—
2.4
—
0
6
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
92.1
—
0
9
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
83
0.96
0.00
1.4
2.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.8
—
0
9
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.0
mg/l
322.2
277.9
—
5
46
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
49
1.02
0.00
1.8
1.3
%
59.2
67.8
—
5
32
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.3
—
0.3
—
0
6
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
0.1
—
0
8
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
23.3
—
0
7
(3027944) Amphetamines [Presence] in Urine
8
86
0.93
0.00
1.4
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
141
1410
1.00
0.00
3.1
3.0
e6/l
1.6
1.1
1.34
85
854
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_STOMACH_ADENO – Adenocarcinoma and papillary adenocarcinoma of stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).